Health Politics Economy Local 2025-12-05T04:21:13+00:00

Economy Secretary and Governor Visit Mexican Radiology Company Booth

At InnovaFest LATAM 2025, Secretary Marcelo Ebrard and Governor Margarita González visited the CMR booth, highlighting the strategic importance of medical technology for Mexico's innovation ecosystem.


Within the framework of InnovaFest LATAM 2025, currently taking place at the Morelos Convention Center, one of the most significant moments of the event was the joint visit of the Secretary of the Economy, Marcelo Ebrard, and the Governor of Morelos, Margarita González, to the booth of Compañía Mexicana de Radiología (CMR). CMR is a national company participating as a key exponent of technological innovation applied to medical diagnosis. The presence of both authorities at the CMR booth stood out due to the strategic importance of the medical technology sector within the innovation ecosystem that InnovaFest aims to consolidate. This type of institutional meeting helps to strengthen the confidence of the private and academic sectors, as well as of investors who see potential for international expansion in national medical solutions. This interaction was interpreted as a significant gesture towards the Mexican biomedical industry, in a scenario where technological sovereignty, the national production of specialized equipment, and the consolidation of local value chains are essential elements to reduce health access gaps. In the context of InnovaFest LATAM 2025 —where topics such as electromobility, biotechnology, aerospace innovation, and sustainability are being analyzed— the authorities' tour of the CMR booth illustrated the need to integrate health technology as a central component in the regional innovation agenda. "This forum brings together representatives from 22 countries and operates as a convergence point for science, industry, universities, and investment funds, but the visit to the CMR booth highlighted the importance of recognizing Mexican companies that develop high-impact solutions in health, especially in a context where diagnostic technology is key to strengthening the clinical response in the country." The attention received by the projects exhibited by CMR reflects an institutional interest in identifying national capabilities that can be scaled to broader platforms for innovation and technology transfer.